These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 25726530)
1. Untreatable tuberculosis: is surgery the answer? Dara M; Sotgiu G; Zaleskis R; Migliori GB Eur Respir J; 2015 Mar; 45(3):577-82. PubMed ID: 25726530 [No Abstract] [Full Text] [Related]
2. [Effectiveness of artificial pneumothorax in the treatment of patients with pulmonary tuberculosis with multiple drug-resistant Mycobacteria]. Chukanov VI; Mishin VIu; Sigaev AT; Vasil'eva IA; Osadchaia OA; Perfil'ev AV; Naumova AN; Bagdasarian TR Probl Tuberk Bolezn Legk; 2004; (8):22-4. PubMed ID: 15478553 [TBL] [Abstract][Full Text] [Related]
3. Changing the game for multidrug-resistant tuberculosis. Ghanashyam B Lancet; 2016 Mar; 387(10024):1149-50. PubMed ID: 27025324 [No Abstract] [Full Text] [Related]
4. MDR tuberculosis challenges global health-care targets. The Lancet Respiratory Medicine Lancet Respir Med; 2013 Dec; 1(10):755. PubMed ID: 24461743 [No Abstract] [Full Text] [Related]
5. Global spotlight falls on tuberculosis. Das P Lancet Infect Dis; 2004 Apr; 4(4):188. PubMed ID: 15072057 [No Abstract] [Full Text] [Related]
6. [Artificial pneumothorax in the combined therapy of destructive pulmonary tuberculosis]. Andrenko AA; Fedorova MV; Grishchenko NG; Tadzhieva NV Probl Tuberk; 1995; (1):43-5. PubMed ID: 7761382 [TBL] [Abstract][Full Text] [Related]
7. Tuberculosis control goals unlikely to be met by 2005. Sharma DC Lancet; 2004 Apr; 363(9415):1122. PubMed ID: 15068013 [No Abstract] [Full Text] [Related]
11. [Efficacy of treatment for pulmonary tuberculosis with multidrug mycobacterial resistance]. Mishin VIu; Chukanov VI; Vasil'eva IA Probl Tuberk; 2002; (12):18-23. PubMed ID: 12611329 [TBL] [Abstract][Full Text] [Related]
12. Totally drug-resistant tuberculosis in India: who let the djinn out? Udwadia ZF Respirology; 2012 Jul; 17(5):741-2. PubMed ID: 22564108 [No Abstract] [Full Text] [Related]
13. Epidemiology of antituberculosis drug resistance (the Global Project on Anti-tuberculosis Drug Resistance Surveillance): an updated analysis. Aziz MA; Wright A; Laszlo A; De Muynck A; Portaels F; Van Deun A; Wells C; Nunn P; Blanc L; Raviglione M; Lancet; 2006 Dec; 368(9553):2142-54. PubMed ID: 17174706 [TBL] [Abstract][Full Text] [Related]
14. Multidrug-resistant tuberculosis: standardized or individualized treatment? The question has already been answered. Laniado-Laborín R Expert Rev Respir Med; 2010 Apr; 4(2):143-6. PubMed ID: 20406077 [No Abstract] [Full Text] [Related]
16. Programmatic versus personalised approaches to managing the global epidemic of multidrug-resistant tuberculosis. Chakaya JM; Marais B; du Cros P; Ntoumi F; Mfinanga S; Kapata N; Hasnain SE; Nathavitharana R; Zumla A Lancet Respir Med; 2020 Apr; 8(4):334-335. PubMed ID: 32113573 [No Abstract] [Full Text] [Related]
17. [Chemotherapy of tuberculosis and its challenges]. Ma Y Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2009 Aug; 31(4):389-92. PubMed ID: 19771720 [TBL] [Abstract][Full Text] [Related]
18. XDR tuberculosis--implications for global public health. Raviglione MC; Smith IM N Engl J Med; 2007 Feb; 356(7):656-9. PubMed ID: 17301295 [No Abstract] [Full Text] [Related]
19. Multidrug-resistant tuberculosis in Ukraine at a time of military conflict. Dudnyk A; Rzhepishevska O; Rogach K; Kutsyna G; Lange C Int J Tuberc Lung Dis; 2015 Apr; 19(4):492-3. PubMed ID: 25860008 [No Abstract] [Full Text] [Related]
20. Drug-resistant tuberculosis: time for visionary political leadership. Abubakar I; Zignol M; Falzon D; Raviglione M; Ditiu L; Masham S; Adetifa I; Ford N; Cox H; Lawn SD; Marais BJ; McHugh TD; Mwaba P; Bates M; Lipman M; Zijenah L; Logan S; McNerney R; Zumla A; Sarda K; Nahid P; Hoelscher M; Pletschette M; Memish ZA; Kim P; Hafner R; Cole S; Migliori GB; Maeurer M; Schito M; Zumla A Lancet Infect Dis; 2013 Jun; 13(6):529-39. PubMed ID: 23531391 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]